AMG319
AMG319
AMG319 (pronounced as A-M-G-Three-One-Nine) is a potent and selective small molecule inhibitor of PI3Kδ (Phosphoinositide 3-kinase delta). It is primarily used in the research of various cancer types, including leukemia and lymphoma.
Etymology
The term "AMG319" is a proprietary name given by the pharmaceutical company Amgen, which developed this molecule. The name does not have a specific etymology as it is a combination of the company's initials and a unique identifier number.
Usage
AMG319 is used in preclinical and clinical studies to inhibit the PI3Kδ pathway, which is often overactive in cancer cells. By blocking this pathway, AMG319 can potentially slow down or stop the growth of cancer cells. It is particularly used in the study of B-cell malignancies, such as chronic lymphocytic leukemia and non-Hodgkin lymphoma.
Related Terms
- Phosphoinositide 3-kinases (PI3Ks): A family of enzymes involved in cellular functions such as cell growth, proliferation, differentiation, motility, survival and intracellular trafficking, which are often deregulated in cancer.
- PI3Kδ inhibitor: A type of drug that blocks the action of PI3Kδ, a specific type of PI3K that is often overactive in cancer cells.
- B-cell: A type of white blood cell that matures into plasma cells and produces antibodies.
See Also
External links
- Medical encyclopedia article on AMG319
- Wikipedia's article - AMG319
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski